+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Women's Health Therapeutics Market 2022-2026

  • PDF Icon

    Report

  • 120 Pages
  • August 2022
  • Region: Global
  • TechNavio
  • ID: 5654463
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The women's health therapeutics market is poised to grow by $30.35 bn during 2022-2026, accelerating at a CAGR of 5.74% during the forecast period. The report on the women's health therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by strategic alliances.

The women's health therapeutics market analysis includes the type segment and geographic landscape.

The women's health therapeutics market is segmented as below:

By Type

  • Fertility
  • Oncology
  • Menopause
  • Infection
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the rising awareness of gynecological diseases as one of the prime reasons driving the women's health therapeutics market growth during the next few years. Also, the emergence of novel therapies and rising government initiatives for antibiotic resistance will lead to sizable demand in the market.

The report on women's health therapeutics market covers the following areas:

  • Women's health therapeutics market sizing
  • Women's health therapeutics market forecast
  • Women's health therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading women's health therapeutics market vendors that include Abbott Laboratories, AbbVie Inc., Amgen Inc., Bayer AG, Eli Lilly and Co., F. Hoffmann La Roche Ltd., GLS Pharma Pvt. Ltd., ICON plc, Merck KGaA, Novartis AG, Novo Nordisk AS, ObsEva SA, Pfizer Inc., Radius Health Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., TSUMURA and Co., Vivesto AB, and Mithra Pharmaceuticals SA. Also, the women's health therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Type
5.1 Market segments
Exhibit 24: Chart on Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
5.2 Comparison by Type
Exhibit 26: Chart on Comparison by Type
Exhibit 27: Data Table on Comparison by Type
5.3 Fertility - Market size and forecast 2021-2026
Exhibit 28: Chart on Fertility - Market size and forecast 2021-2026 ($ billion)
Exhibit 29: Data Table on Fertility - Market size and forecast 2021-2026 ($ billion)
Exhibit 30: Chart on Fertility - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Fertility - Year-over-year growth 2021-2026 (%)
5.4 Oncology - Market size and forecast 2021-2026
Exhibit 32: Chart on Oncology - Market size and forecast 2021-2026 ($ billion)
Exhibit 33: Data Table on Oncology - Market size and forecast 2021-2026 ($ billion)
Exhibit 34: Chart on Oncology - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Oncology - Year-over-year growth 2021-2026 (%)
5.5 Menopause - Market size and forecast 2021-2026
Exhibit 36: Chart on Menopause - Market size and forecast 2021-2026 ($ billion)
Exhibit 37: Data Table on Menopause - Market size and forecast 2021-2026 ($ billion)
Exhibit 38: Chart on Menopause - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Menopause - Year-over-year growth 2021-2026 (%)
5.6 Infection - Market size and forecast 2021-2026
Exhibit 40: Chart on Infection - Market size and forecast 2021-2026 ($ billion)
Exhibit 41: Data Table on Infection - Market size and forecast 2021-2026 ($ billion)
Exhibit 42: Chart on Infection - Year-over-year growth 2021-2026 (%)
Exhibit 43: Data Table on Infection - Year-over-year growth 2021-2026 (%)
5.7 Others - Market size and forecast 2021-2026
Exhibit 44: Chart on Others - Market size and forecast 2021-2026 ($ billion)
Exhibit 45: Data Table on Others - Market size and forecast 2021-2026 ($ billion)
Exhibit 46: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibit 47: Data Table on Others - Year-over-year growth 2021-2026 (%)
5.8 Market opportunity by Type
Exhibit 48: Market opportunity by Type ($ billion)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 50: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 52: Chart on Geographic comparison
Exhibit 53: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 54: Chart on North America - Market size and forecast 2021-2026 ($ billion)
Exhibit 55: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
Exhibit 56: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 58: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibit 59: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibit 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 62: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibit 63: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibit 64: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibit 67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibit 68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ billion)
Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ billion)
Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 UK - Market size and forecast 2021-2026
Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ billion)
Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.10 China - Market size and forecast 2021-2026
Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ billion)
Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ billion)
Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)
7.11 Canada - Market size and forecast 2021-2026
Exhibit 86: Chart on Canada - Market size and forecast 2021-2026 ($ billion)
Exhibit 87: Data Table on Canada - Market size and forecast 2021-2026 ($ billion)
Exhibit 88: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 89: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 90: Market opportunity By Geographical Landscape ($ billion)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 91: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 93: Overview on factors of disruption
9.4 Industry risks
Exhibit 94: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 95: Vendors covered
10.2 Market positioning of vendors
Exhibit 96: Matrix on vendor position and classification
10.3 Abbott Laboratories
Exhibit 97: Abbott Laboratories - Overview
Exhibit 98: Abbott Laboratories - Business segments
Exhibit 99: Abbott Laboratories - Key news
Exhibit 100: Abbott Laboratories - Key offerings
Exhibit 101: Abbott Laboratories - Segment focus
10.4 AbbVie Inc.
Exhibit 102: AbbVie Inc. - Overview
Exhibit 103: AbbVie Inc. - Product / Service
Exhibit 104: AbbVie Inc. - Key offerings
10.5 Amgen Inc.
Exhibit 105: Amgen Inc. - Overview
Exhibit 106: Amgen Inc. - Product / Service
Exhibit 107: Amgen Inc. - Key offerings
10.6 Bayer AG
Exhibit 108: Bayer AG - Overview
Exhibit 109: Bayer AG - Business segments
Exhibit 110: Bayer AG - Key offerings
Exhibit 111: Bayer AG - Segment focus
10.7 Eli Lilly and Co.
Exhibit 112: Eli Lilly and Co. - Overview
Exhibit 113: Eli Lilly and Co. - Product / Service
Exhibit 114: Eli Lilly and Co. - Key offerings
10.8 F. Hoffmann La Roche Ltd.
Exhibit 115: F. Hoffmann La Roche Ltd. - Overview
Exhibit 116: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 117: F. Hoffmann La Roche Ltd. - Key news
Exhibit 118: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 119: F. Hoffmann La Roche Ltd. - Segment focus
10.9 ICON plc
Exhibit 120: ICON plc - Overview
Exhibit 121: ICON plc - Product / Service
Exhibit 122: ICON plc - Key offerings
10.10 Merck KGaA
Exhibit 123: Merck KGaA - Overview
Exhibit 124: Merck KGaA - Business segments
Exhibit 125: Merck KGaA - Key news
Exhibit 126: Merck KGaA - Key offerings
Exhibit 127: Merck KGaA - Segment focus
10.11 Mithra Pharmaceuticals SA
Exhibit 128: Mithra Pharmaceuticals SA - Overview
Exhibit 129: Mithra Pharmaceuticals SA - Product / Service
Exhibit 130: Mithra Pharmaceuticals SA - Key offerings
10.12 Novartis AG
Exhibit 131: Novartis AG - Overview
Exhibit 132: Novartis AG - Business segments
Exhibit 133: Novartis AG - Key offerings
Exhibit 134: Novartis AG - Segment focus
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 135: Inclusions checklist
Exhibit 136: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 137: Currency conversion rates for US$
11.4 Research methodology
Exhibit 138: Research methodology
Exhibit 139: Validation techniques employed for market sizing
Exhibit 140: Information sources
11.5 List of abbreviations
Exhibit 141: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Vendor Market Positioning
Exhibits 9: Parent market
Exhibits 10: Market Characteristics
Exhibits 11: Offerings of vendors included in the market definition
Exhibits 12: Market segments
Exhibits 13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
Exhibits 14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
Exhibits 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 17: Five forces analysis - Comparison between 2021 and 2026
Exhibits 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits 23: Chart on Market condition - Five forces 2021 and 2026
Exhibits 24: Chart on Type - Market share 2021-2026 (%)
Exhibits 25: Data Table on Type - Market share 2021-2026 (%)
Exhibits 26: Chart on Comparison by Type
Exhibits 27: Data Table on Comparison by Type
Exhibits 28: Chart on Fertility - Market size and forecast 2021-2026 ($ billion)
Exhibits 29: Data Table on Fertility - Market size and forecast 2021-2026 ($ billion)
Exhibits 30: Chart on Fertility - Year-over-year growth 2021-2026 (%)
Exhibits 31: Data Table on Fertility - Year-over-year growth 2021-2026 (%)
Exhibits 32: Chart on Oncology - Market size and forecast 2021-2026 ($ billion)
Exhibits 33: Data Table on Oncology - Market size and forecast 2021-2026 ($ billion)
Exhibits 34: Chart on Oncology - Year-over-year growth 2021-2026 (%)
Exhibits 35: Data Table on Oncology - Year-over-year growth 2021-2026 (%)
Exhibits 36: Chart on Menopause - Market size and forecast 2021-2026 ($ billion)
Exhibits 37: Data Table on Menopause - Market size and forecast 2021-2026 ($ billion)
Exhibits 38: Chart on Menopause - Year-over-year growth 2021-2026 (%)
Exhibits 39: Data Table on Menopause - Year-over-year growth 2021-2026 (%)
Exhibits 40: Chart on Infection - Market size and forecast 2021-2026 ($ billion)
Exhibits 41: Data Table on Infection - Market size and forecast 2021-2026 ($ billion)
Exhibits 42: Chart on Infection - Year-over-year growth 2021-2026 (%)
Exhibits 43: Data Table on Infection - Year-over-year growth 2021-2026 (%)
Exhibits 44: Chart on Others - Market size and forecast 2021-2026 ($ billion)
Exhibits 45: Data Table on Others - Market size and forecast 2021-2026 ($ billion)
Exhibits 46: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits 47: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits 48: Market opportunity by Type ($ billion)
Exhibits 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 50: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 52: Chart on Geographic comparison
Exhibits 53: Data Table on Geographic comparison
Exhibits 54: Chart on North America - Market size and forecast 2021-2026 ($ billion)
Exhibits 55: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
Exhibits 56: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits 57: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits 58: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibits 59: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibits 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 62: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibits 63: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibits 64: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibits 67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibits 68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 70: Chart on US - Market size and forecast 2021-2026 ($ billion)
Exhibits 71: Data Table on US - Market size and forecast 2021-2026 ($ billion)
Exhibits 72: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits 73: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits 74: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibits 75: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibits 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 78: Chart on UK - Market size and forecast 2021-2026 ($ billion)
Exhibits 79: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
Exhibits 80: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits 82: Chart on China - Market size and forecast 2021-2026 ($ billion)
Exhibits 83: Data Table on China - Market size and forecast 2021-2026 ($ billion)
Exhibits 84: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits 85: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits 86: Chart on Canada - Market size and forecast 2021-2026 ($ billion)
Exhibits 87: Data Table on Canada - Market size and forecast 2021-2026 ($ billion)
Exhibits 88: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 89: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 90: Market opportunity By Geographical Landscape ($ billion)
Exhibits 91: Impact of drivers and challenges in 2021 and 2026
Exhibits 92: Overview on Criticality of inputs and Factors of differentiation
Exhibits 93: Overview on factors of disruption
Exhibits 94: Impact of key risks on business
Exhibits 95: Vendors covered
Exhibits 96: Matrix on vendor position and classification
Exhibits 97: Abbott Laboratories - Overview
Exhibits 98: Abbott Laboratories - Business segments
Exhibits 99: Abbott Laboratories - Key news
Exhibits 100: Abbott Laboratories - Key offerings
Exhibits 101: Abbott Laboratories - Segment focus
Exhibits 102: AbbVie Inc. - Overview
Exhibits 103: AbbVie Inc. - Product / Service
Exhibits 104: AbbVie Inc. - Key offerings
Exhibits 105: Amgen Inc. - Overview
Exhibits 106: Amgen Inc. - Product / Service
Exhibits 107: Amgen Inc. - Key offerings
Exhibits 108: Bayer AG - Overview
Exhibits 109: Bayer AG - Business segments
Exhibits 110: Bayer AG - Key offerings
Exhibits 111: Bayer AG - Segment focus
Exhibits 112: Eli Lilly and Co. - Overview
Exhibits 113: Eli Lilly and Co. - Product / Service
Exhibits 114: Eli Lilly and Co. - Key offerings
Exhibits 115: F. Hoffmann La Roche Ltd. - Overview
Exhibits 116: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 117: F. Hoffmann La Roche Ltd. - Key news
Exhibits 118: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 119: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 120: ICON plc - Overview
Exhibits 121: ICON plc - Product / Service
Exhibits 122: ICON plc - Key offerings
Exhibits 123: Merck KGaA - Overview
Exhibits 124: Merck KGaA - Business segments
Exhibits 125: Merck KGaA - Key news
Exhibits 126: Merck KGaA - Key offerings
Exhibits 127: Merck KGaA - Segment focus
Exhibits 128: Mithra Pharmaceuticals SA - Overview
Exhibits 129: Mithra Pharmaceuticals SA - Product / Service
Exhibits 130: Mithra Pharmaceuticals SA - Key offerings
Exhibits 131: Novartis AG - Overview
Exhibits 132: Novartis AG - Business segments
Exhibits 133: Novartis AG - Key offerings
Exhibits 134: Novartis AG - Segment focus
Exhibits 135: Inclusions checklist
Exhibits 136: Exclusions checklist
Exhibits 137: Currency conversion rates for US$
Exhibits 138: Research methodology
Exhibits 139: Validation techniques employed for market sizing
Exhibits 140: Information sources
Exhibits 141: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global women's health therapeutics market: Abbott Laboratories, AbbVie Inc., Amgen Inc., Bayer AG, Eli Lilly and Co., F. Hoffmann La Roche Ltd., GLS Pharma Pvt. Ltd., ICON plc, Merck KGaA, Novartis AG, Novo Nordisk AS, ObsEva SA, Pfizer Inc., Radius Health Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., TSUMURA and Co., Vivesto AB, and Mithra Pharmaceuticals SA.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is rising awareness of gynecological diseases.`

According to the report, one of the major drivers for this market is the strategic alliances.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • AbbVie Inc.
  • Amgen Inc.
  • Bayer AG
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • GLS Pharma Pvt. Ltd.
  • ICON plc
  • Merck KGaA
  • Novartis AG
  • Novo Nordisk AS
  • ObsEva SA
  • Pfizer Inc.
  • Radius Health Inc.
  • Sanofi SA
  • Takeda Pharmaceutical Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • TSUMURA and Co.
  • Vivesto AB
  • Mithra Pharmaceuticals SA